U.S. Senate Committee on Health, Education, Labor, and Pensions

09/24/2024 | Press release | Distributed by Public on 09/24/2024 11:16

MAJORITY STAFF REPORT: Novo Nordisk’s Untenable Drug Pricing Strategy in America: Greed, Greed, Greed

Read the full report, HERE.

U.S. Senate Committee on Health, Education, Labor, and Pensions published this content on September 24, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on September 24, 2024 at 17:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]